Not Yet RecruitingNot Applicable

Manual Acupuncture for Acute Primary Tinnitus

China180 participantsStarted 2026-06-15

Plain-language summary

This clinical trial aims to assess the efficacy of manual acupuncture for patients with acute primary tinnitus.

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Aged 18-65 years, male or female;
. Primary complaint is persistent tinnitus (unilateral or bilateral);
. Meet the diagnostic criteria for primary tinnitus according to the 2014 Clinical Practice Guideline developed by the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF);
. Had continuous tinnitus ≥2 weeks and \<6 months;
. Tinnitus should be bothersome, with a screening THI score 28-76;
. Acupuncture naive;
. Able to provide written informed consent.

Exclusion criteria

. Objective tinnitus;
. Pulsatile tinnitus;
. Diagnosed as secondary tinnitus as evaluated by audiologists and clinicians(Menière's disease, temporomandibular joint disorder or other diseases);
. Had evidence of conductive hearing loss (confirmed by abnormal otoscopy or tympanogram);

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Tinnitus Handicap Inventory (THI, 0-100)

Timeframe: Baseline visit, end of treatment at 4 weeks after randomization, post-treatment at 8 weeks after randomization and 12 weeks after randomization.

Tinnitus Functional Index (TFI, 0-100)

Timeframe: Baseline visit, end of treatment at 4 weeks after randomization, post-treatment at 8 weeks after randomization and 12 weeks after randomization.

Trial details

NCT IDNCT07515482

SponsorDan Bing

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-10-30

Contact for this trial

Dan Bing, PhD

86+13971058388 didibing1981@aliyun.com

View on ClinicalTrials.gov More Tinnitus trials

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Aged 18-65 years, male or female;
. Primary complaint is persistent tinnitus (unilateral or bilateral);
. Meet the diagnostic criteria for primary tinnitus according to the 2014 Clinical Practice Guideline developed by the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF);
. Had continuous tinnitus ≥2 weeks and \<6 months;
. Tinnitus should be bothersome, with a screening THI score 28-76;
. Acupuncture naive;
. Able to provide written informed consent.

Exclusion criteria

. Objective tinnitus;
. Pulsatile tinnitus;
. Diagnosed as secondary tinnitus as evaluated by audiologists and clinicians(Menière's disease, temporomandibular joint disorder or other diseases);
. Had evidence of conductive hearing loss (confirmed by abnormal otoscopy or tympanogram);

What they're measuring

Tinnitus Handicap Inventory (THI, 0-100)

Timeframe: Baseline visit, end of treatment at 4 weeks after randomization, post-treatment at 8 weeks after randomization and 12 weeks after randomization.

Tinnitus Functional Index (TFI, 0-100)

Timeframe: Baseline visit, end of treatment at 4 weeks after randomization, post-treatment at 8 weeks after randomization and 12 weeks after randomization.